Alerts

Medicine shortage alert

Robust Extreme capsules pose a serious risk to your health and should not be taken.

Shortage resolved

The TGA has received reports of serious adverse events in infants and children who have been given compounded wind and colic preparations containing Atropa belladonna (belladonna).

Read our safety advisory about this ingredient's potential to cause severe allergic reactions including anaphylaxis.

Due to Oxynorm being reinstated in Australia and Ordine shortage extension

Current shortage of Vyvanse 20 mg and anticipated shortage of Vyvanse 60mg capsules.

The affected bi-level positive airway pressure (BiPAP) devices may stop providing therapy on an intermittent or permanent basis and the ‘Ventilator Inoperative’ alarm will sound.

Fluoxetine substitution instrument has been extended.

extension of SSSI

Pharmacists can now substitute one Orencia 125 mg product for the other

Find out about the shortage of Orencia (abatacept) 125 mg/mL ClickJect autoinjector and prefilled syringe for subcutaneous injection.

All strengths of Vyvanse capsules are now available.

Dark Horse Capsules pose a serious risk to your health and should not be taken.

If the dosing syringe is stiff and difficult to use, you may not be able to control the delivery of the medicine. This poses a risk of choking, especially for babies.

Shortages of both Orencia (abatacept) 125 mg products, the ClickJect prefilled autoinjector and prefilled syringe for subcutaneous injection, are anticipated from early to mid-June 2024. Find out more.

This shortage has been extended

The shortage of Vyvanse 60 mg has been extended to 30 April 2024

Pfizer Australia has advised that the shortage of Bicillin L-A prefilled syringe for injection will continue until mid-2024, so we have approved the importation and supply of a second overseas-registered product, Extencilline benzathine benzylpenicillin 1.2 million unit vial (France), until 30 September 2024.

Be alert to the issue of unexpected shut down of the A30 and A40 series bi-level positive airway pressure (BiPAP) devices. This can cause interruptions and loss of therapy for patients.

Be alert about a higher risk of device failure with the Hintermann Series H3 Total Ankle Replacement (TAR) system. Read this if you're a patient, carer or health care provider.

The companies supplying Fanttest COVID-19 test kits were made aware of the potential for variability in the way the control line appears (ie a weak/faint/pale control line) when strong COVID-19 positive results are obtained.

The product tested is not listed in the ARTG and has not been assessed by the TGA for quality, safety or efficacy as required under Australian legislation.

Sun Herbal Pty Ltd is recalling Clear the Skin Formula a.k.a. Liang Xue Xiao Feng San CM116, a Chinese medicine for skin rash because the label does not display the required warning statement.

Metalyse (tenecteplase) 40 mg for injection is to be discontinued; supply of Metalyse 50 mg for injection is not affected.